IKT
IKT
NASDAQ · Biotechnology

Inhibikase Therapeutics Inc

$1.52
-0.01 (-0.65%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 12 86%
Hold 2 14%
Sell 0 0%
Price Target
Analyst Price Target +1,742.8% upside
Low Target $19.41
Average Target $28.01
High Target $39.32
Current Price $1.52
Current
$1.52
Target
$28.01
$19.41 $28.01 avg $39.32
Scenario Analysis
Bear Case
$19.41
1,177.0%
Low target
Base Case
$28.01
+1,742.8%
Avg target
Bull Case
$39.32
+2,486.8%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$2.61
-41.8% from high
52-Week Low
$1.40
+8.6% from low
Target vs 52W High
$28.01
+973.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.7%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.3%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.3%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -92.0%
MRNA
Moderna Inc
Hold 31 32% $149.45 -31.8%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -51.4%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -32.5%